Literature DB >> 20455638

Preliminary treatment considerations among men with newly diagnosed prostate cancer.

Steven B Zeliadt1, Carol M Moinpour, David K Blough, David F Penson, Ingrid J Hall, Judith Lee Smith, Donatus U Ekwueme, Ian M Thompson, Thomas E Keane, Scott D Ramsey.   

Abstract

OBJECTIVE: To assess factors that may influence men's preference for surgery versus nonsurgical options among newly diagnosed patients considering treatments for local-stage prostate cancer. STUDY
DESIGN: Prostate cancer patients were approached at urology clinics after diagnosis but prior to starting treatment in California, South Carolina, and Texas. Using a survey about the treatment decision-making process, patients were asked about their likes and dislikes of 5 common treatment options: surgery (prostatectomy), brachytherapy, external beam radiation therapy, hormone therapy, and watchful waiting.
METHODS: Logistic regression identified associations between treatment characteristics and choice of prostatectomy compared with nonsurgical options, controlling for demographic, clinical, and psychological covariates.
RESULTS: Of the 198 eligible men who returned the baseline survey, 59% indicated they only considered surgery and 41% considered at least 1 nonsurgical option. In multivariate analysis, patients who thought treatment efficacy was a primary concern were significantly more likely to prefer surgery only (odds ratio [OR] = 6.20, 95% confidence interval [95% CI] = 1.74, 22.10); those indicating concern about personal burden were significantly more likely to prefer nonsurgical options (OR = 0.07, 95% CI = 0.02, 0.22). Advice of friends and relatives and concerns over side effects were not significantly associated with preference for surgery versus other treatments.
CONCLUSIONS: Men's perceptions about treatment efficacy and the personal burden of treatment dominated preferences for surgery versus nonsurgical options. Interventions to aid treatment decision making should account for these elements to minimize the impact of physician biases and patient misperceptions on men's decisions as how best to manage their prostate cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20455638

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  25 in total

1.  Decision-making processes among men with low-risk prostate cancer: A survey study.

Authors:  Richard M Hoffman; Stephen K Van Den Eeden; Kimberly M Davis; Tania Lobo; George Luta; Jun Shan; David Aaronson; David F Penson; Amethyst D Leimpeter; Kathryn L Taylor
Journal:  Psychooncology       Date:  2017-07-13       Impact factor: 3.894

2.  Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences.

Authors:  Scott D Ramsey; Steven B Zeliadt; David K Blough; Carol M Moinpour; Ingrid J Hall; Judith Lee Smith; Donatus U Ekwueme; Catherine R Fedorenko; Megan E Fairweather; Lisel M Koepl; Ian M Thompson; Thomas E Keane; David F Penson
Journal:  J Sex Med       Date:  2013-09-30       Impact factor: 3.802

3.  Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

Authors:  Benjamin M Johnson; Bently P Doonan; Faisal F Radwan; Azizul Haque
Journal:  Open Prost Cancer J       Date:  2010-01-01

4.  Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer.

Authors:  Donna L Berry; Qian Wang; Barbara Halpenny; Fangxin Hong
Journal:  Patient Educ Couns       Date:  2012-05-17

5.  Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective.

Authors:  Chunyu Li; Steven B Zeliadt; Ingrid J Hall; Judith Lee Smith; Donatus U Ekwueme; Carol M Moinpour; David F Penson; Ian M Thompson; Thomas E Keane; Scott D Ramsey
Journal:  Support Care Cancer       Date:  2013-08-17       Impact factor: 3.603

6.  Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.

Authors:  Jinping Xu; James Janisse; Julie Ruterbusch; Joel Ager; Kendra L Schwartz
Journal:  J Racial Ethn Health Disparities       Date:  2015-05-05

7.  Patient, Physician and Contextual Factors Are Influential in the Treatment Decision Making of Older Adults Newly Diagnosed with Symptomatic Myeloma.

Authors:  Joseph D Tariman; Ardith Doorenbos; Karen G Schepp; Pamela S Becker; Donna L Berry
Journal:  Cancer Treat Commun       Date:  2014

8.  A comparison of general, genitourinary, bowel, and sexual quality of life among long term survivors of prostate, bladder, colorectal, and lung cancer.

Authors:  Scott D Ramsey; Ingrid J Hall; Judith Lee Smith; Donatus U Ekwueme; Catherine R Fedorenko; Karma Kreizenbeck; Aasthaa Bansal; Ian M Thompson; David F Penson
Journal:  J Geriatr Oncol       Date:  2020-07-29       Impact factor: 3.599

9.  Development and validation of the korean version of expanded prostate cancer index composite: questionnaire assessing health-related quality of life after prostate cancer treatment.

Authors:  Kyung Jin Chung; Jung Jun Kim; Soo Hyun Lim; Tae Heon Kim; Deok Hyun Han; Sung Won Lee
Journal:  Korean J Urol       Date:  2010-09-16

10.  Assessment of the status of a National Action Plan for Cancer Survivorship in the USA.

Authors:  Judith Lee Smith; Lori A Pollack; Juan L Rodriguez; Nikki A Hawkins; Tenbroeck Smith; Ruth Rechis; Andy Miller; Anne Willis; Helen Miller; Ingrid J Hall; Temeika L Fairley; Brenda Stone-Wiggins
Journal:  J Cancer Surviv       Date:  2013-04-23       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.